The FDA has set a PDUFA target action date of May 22, 2025. Read more. ClinicalPlaque PsoriasisFDA News. Advertisement. “In clinical studies …
FDA Accepts sNDA for Roflumilast Foam as Scalp, Body Psoriasis Treatment – HCPLive
Share This Story, Choose Your Platform!
About the Author:
